Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02180724
Brief Title: An Open-label, Phase 2 Study of Acalabrutinib in Subjects With Waldenström Macroglobulinemia

First Submitted : June 30, 2014
First Submitted that Met QC Criteria : July 1, 2014
First Posted : July 3, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : January 31, 2019
Last Update Posted : February 1, 2019